[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334502-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334502-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","reciprocal-regulation-of-lncrna-mef-and-c-myc-drives-colorectal-cancer-tumorigenesis","Reciprocal regulation of lncRNA MEF and c-Myc drives colorectal cancer tumorigenesis","","More than half of all cancers show aberrant c-Myc expression, and deregulated long non-coding RNAs (lncRNAs) can modulate c-Myc. This study shows that the lncRNA MEF (c-Myc Enhancing Factor) cooperates with c-Myc as both a transcriptional target and driver. MEF binds and stabilizes hnRNPK, disrupts hnRNPK binding to TRIM25, reducing hnRNPK ubiquitination and degradation while enhancing c-Myc translation. MEF is required for CRC proliferation and survival in vitro and in vivo, and is upregulated in patient tissues with correlations supporting a positive feedback loop, supporting MEF as a therapeutic target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/reciprocal-regulation-of-lncrna-mef-and-c-myc-drives-colorectal-cancer-tumorigenesis/334502/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/reciprocal-regulation-of-lncrna-mef-and-c-myc-drives-colorectal-cancer-tumorigenesis/334502.png","ImageObject",300,407,{"name":42,"@type":43},"Himbo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is MEF and how does it relate to c-Myc in colorectal cancer?","Question",{"text":63,"@type":64},"MEF is a lncRNA (c-Myc Enhancing Factor) that cooperatively regulates c-Myc. It functions both as a transcriptional target of c-Myc and as a driver that enhances c-Myc expression.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does MEF regulate hnRNPK to affect c-Myc?",{"text":68,"@type":64},"MEF binds to and stabilizes hnRNPK. This disrupts hnRNPK binding to the E3 ubiquitin ligase TRIM25, attenuating TRIM25-dependent ubiquitination and proteasomal destruction, which enhances c-Myc via increased translation.",{"name":70,"@type":61,"acceptedAnswer":71},"What evidence links MEF to colorectal cancer growth and clinical relevance?",{"text":72,"@type":64},"MEF knockdown and overexpression show MEF is essential for colorectal cancer cell proliferation and survival in vitro and in vivo. Clinically, MEF expression is higher in colorectal cancer tissues than normal adjacent tissues and correlates with c-Myc and hnRNPK, suggesting an active positive feedback loop.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334502,1790236477,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","Neoplasia 49 (2024) 100971  \nContents lists available at ScienceDirect  \nNeoplasia  \njournal [homepage:](homepage: www.elsevier.com/locate/neo)[ www.elsevier.com/locate/neo](homepage: www.elsevier.com/locate/neo)  \n| Original Research\u003Cbr>Reciprocal regulation of lncRNA MEF and c-Myc drives colorectal cancer tumorigenesis |  |  | |\n| --- | --- | --- | --- |\n| Shuang Wu a, 1, Xiangyu Daia, b, 4, Zhipu Zhub, 1, Dianhui Fana, Su Jiang 1, Yi Dong b, Bing Chen b, Qi Xieb, Zhihui Yao b, Qun Lia, Rick Francis Thorne b, Yao Luc, *, Hao Gua, *, Wanglai Hua, b, *\u003Cbr>a Department of Immunology, School of Basic Medical Sciences, Anhui Medical University, Hefei 230027, China\u003Cbr>b Translational Research Institute, People’s Hospital of Zhengzhou University, Academy of Medical Science, Henan International Joint Laboratory of Non-coding RNA and Metabolism in Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou University, Zhengzhou, 450003, China\u003Cbr>c Department of Anesthesiology, the First Affiliated ofAnhui Medical University, Anhui Medical University, Hefei 230022, China |  |  |  |\n| A R T I C L E I N F O |  | A B S T R A C T |  |\n| Keywords:\u003Cbr>c-Myc\u003Cbr>lncRNA-MEF hnRNPK TRIM25 Colorectal cancer |  | More than half of all cancers demonstrate aberrant c-Myc expression, making this arguably the most important human oncogene. Deregulated long non-coding RNAs (lncRNAs) are also commonly implicated in tumorigenesis, and some limited examples have been established where lncRNAs act as biological tuners of c-Myc expression and activity. Here, we demonstrate that the lncRNA denoted c-Myc Enhancing Factor (MEF) enjoys a cooperative relationship with c-Myc, both as a transcriptional target and driver of c-Myc expression. Mechanistically, MEF functions by binding to and stabilizing the expression of hnRNPK in colorectal cancer cells. The MEF-hnRNPK interaction serves to disrupt binding between hnRNPK and the E3 ubiquitin ligase TRIM25, which attenuates TRIM25-dependent hnRNPK ubiquitination and proteasomal destruction. In turn, the stabilization of hnRNPK through MEF enhances c-Myc expression by augmenting the translation c-Myc. Moreover, modulating the expression of MEF in shRNA-mediated knockdown and overexpression studies revealed that MEF expression is essential for colorectal cancer cell proliferation and survival, both in vitro and in vivo. From the clinical perspective, we show that MEF expression is differentially increased in colorectal cancer tissues compared to normal adjacent tissues. Further, correlations exist between MEF, c-Myc, and hnRNPK suggesting the MEF-c-Myc positive feedback loop is active in patients. Together these data demonstrate that MEF is a pivotal partner of the c-Myc network and propose MEF as a valuable therapeutic target for colorectal cancer. |  |\n\nIntroduction  \nThe protooncogene c-Myc is a dominant driver of tumorigenesis and represents one of the most promising cancer therapeutic targets [1]. Fundamentally a transcription factor, c-Myc has been shown to control 10 to 15 % of genes in the human genome and is also suggested to be a global amplifier of active promoters [2]. Importantly, c-Myc is aberrantly activated in ~40 % of all human cancers, variously resulting from gene amplification, chromosomal translocations or by upstream growth  \nfactor signaling [3,4]. Despite arising through heterogeneous mechanisms, c-Myc up-regulation and/or activation occurs in the large majority of certain cancer types, for example, in up to 70 % of cases colorectal cancer (CRC) [5,6]. As such, c-Myc upregulation contributes to the cancer initiation and development through controlling the cell cycle and proliferation, along with variety of diverse cellular events ranging from metabolism to apoptosis [3,7,8]. Considering the significant contribution of c-Myc to oncogenesis, its expression and activity must be strictly regulated where a variety of tran","cbCaibnKExQlv9Nn","https://ap.wps.com/l/cbCaibnKExQlv9Nn","pdf",6915301,13,"English","# Introduction\n## c-Myc as a driver and therapeutic target\n## Role of long noncoding RNAs in c-Myc regulation\n# Keywords and study focus\n# Article information (authors, affiliations, dates, license)","[{\"question\":\"What is MEF and how does it relate to c-Myc in colorectal cancer?\",\"answer\":\"MEF is a lncRNA (c-Myc Enhancing Factor) that cooperatively regulates c-Myc. It functions both as a transcriptional target of c-Myc and as a driver that enhances c-Myc expression.\"},{\"question\":\"How does MEF regulate hnRNPK to affect c-Myc?\",\"answer\":\"MEF binds to and stabilizes hnRNPK. This disrupts hnRNPK binding to the E3 ubiquitin ligase TRIM25, attenuating TRIM25-dependent ubiquitination and proteasomal destruction, which enhances c-Myc via increased translation.\"},{\"question\":\"What evidence links MEF to colorectal cancer growth and clinical relevance?\",\"answer\":\"MEF knockdown and overexpression show MEF is essential for colorectal cancer cell proliferation and survival in vitro and in vivo. Clinically, MEF expression is higher in colorectal cancer tissues than normal adjacent tissues and correlates with c-Myc and hnRNPK, suggesting an active positive feedback loop.\"}]","Reciprocal regulation of lncRNA MEF and c-Myc drives colorectal cancer tumorigenesis | PDF",1790006931,33]